Crinetics Pharmaceuticals, Inc. (CRNX) is a publicly traded Healthcare sector company. As of August 24, 2026, CRNX trades at $84.69 with a market cap of $8.99B and a P/E ratio of -16.80. CRNX moved +0.02% today. Year to date, CRNX is +81.93%; over the trailing twelve months it is +188.06%. Its 52-week range spans $24.10 to $84.80. Analyst consensus is neutral with an average price target of $85.56. Rallies surfaces CRNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks CRNX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $84.69 |
| Market Cap | $8.99B |
| P/E Ratio | -16.80 |
| EPS | $-5.04 |
| Dividend Yield | 0.00% |
| 52-Week High | $84.80 |
| 52-Week Low | $24.10 |
| Volume | 1.41M |
| Avg Volume | 0 |
| Revenue (TTM) | $42.16M |
| Net Income | $-501.61M |
| Gross Margin | 0.00% |
14 analysts cover CRNX: 0 strong buy, 2 buy, 12 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $85.56.